BPI-15086
BPI-15086 is an orally bioavailable, irreversible tyrosine kinase inhibitor selective for EGFR mutants, including the T790M resistance mutation. It is a research tool for studying non-small cell lung cancer (NSCLC) in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1644502-33-9
Field of Research
Cardiovascular Research, Immunology & Inflammation, Signal Transduction
Smiles
O=C (C=C) NC1=CC (NC2=NC=C (Cl) C (=N2) NC=3C=CC=CC3C (=O) C (=O) N (C) C) =C (OC) C=C1N4CCN (C) CC4
Molecular Formula
C29H33ClN8O4
Molecular Weight
593.08
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1372924-01 0.02 mg (E-Coli)
Recombinant Xanthomonas axonopodis pv. citri ATP phosphoribosyltransferase (hisG)
Sign In for Pricing
View Details MBS1372924-02 0.02 mg (Yeast)
Recombinant Xanthomonas axonopodis pv. citri ATP phosphoribosyltransferase (hisG)
Sign In for Pricing
View Details MBS1372924-03 0.1 mg (E-Coli)
Recombinant Xanthomonas axonopodis pv. citri ATP phosphoribosyltransferase (hisG)
Sign In for Pricing
View Details MBS1372924-04 0.1 mg (Yeast)
Recombinant Xanthomonas axonopodis pv. citri ATP phosphoribosyltransferase (hisG)
Sign In for Pricing
View Details MBS1372924-05 0.02 mg (Baculovirus)
Recombinant Xanthomonas axonopodis pv. citri ATP phosphoribosyltransferase (hisG)
Sign In for Pricing
View Details MBS1372924-06 0.02 mg (Mammalian-Cell)
Recombinant Xanthomonas axonopodis pv. citri ATP phosphoribosyltransferase (hisG)
Sign In for Pricing
View Details